<a href="https://www.prnewswire.com/news-releases/flagship-pioneering-launches-sigilon-therapeutics-to-advance-afibromer-encapsulated-cell-therapies-300477188.html" target="_blank">Flagship Pioneering Launches Sigilon Therapeutics to Advance Afibromer™ Encapsulated Cell Therapies</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>

Flagship Pioneering Launches Sigilon Therapeutics to Advance Afibromer™ Encapsulated Cell Therapies - PR Newswire

<a href="https://news.google.com/__i/rss/rd/articles/CBMimgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZsYWdzaGlwLXBpb25lZXJpbmctbGF1bmNoZXMtc2lnaWxvbi10aGVyYXBldXRpY3MtdG8tYWR2YW5jZS1hZmlicm9tZXItZW5jYXBzdWxhdGVkLWNlbGwtdGhlcmFwaWVzLTMwMDQ3NzE4OC5odG1s0gEA?oc=5" target="_blank">Flagship Pioneering Launches Sigilon Therapeutics to Advance ...</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>

Flagship Pioneering Launches Sigilon Therapeutics to Advance ... - PR Newswire

Harvard University

Yale University

Harvard Medical School

Stanford University School of Medicine

Health Care Investor and Consultant

Minneapolis, Minnesota, United States

Numerous public and privately held  companies

Health Care Consultant

Public Company (NYSE: FNA)

Quality,Technology and Compliance Committee , Chair
Nominating /Governance Committee

Paragon 28

Board Director

The G2 Bio Companies were founded in 2021 to fund and develop potential next-generation gene therapy candidates from the University of Pennsylvania Gene Therapy Program. The companies are based in Philadelphia, PA and funded by Temasek Holdings, Singapore

G2 Bio Companies

Joint Steering Committee Member

CBC Group

Sr.Advisor

Global leader in the supply of auto-injectors

SHL Medical

Independent Board Director

Public company, Hong Kong Exchange (9996.HK), Structural Heart and Neuro Interventions

Nominating Committee
Compensation Committee

Peijia Medical (Suzhou) Co., Ltd

Independent Non Executive Board Director

Cathay Capital

Venture Partner

Public Company: (NYSE: BAX)
Chair, Quality,Technology & Compliance Committee
Member of Governance Committee

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For 90 years, Baxter has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit <a href="http://www.baxter.com">www.baxter.com</a>

Baxter International Inc.

Compensation Committee

Late stage venture backed biotech company focused targeted precision delivery of gene therapies to the central nervous system and spinal cord

Alcyone Therapeutics Inc.

Public biotech (NASDAQ: SGTX) company in the cell therapy space
Audit Committee
Governance Committee

Sigilon developed a Shielded Living Therapeutics™ platform to address myriad treatment challenges. Leveraging advances in cell engineering and our proprietary biocompatible materials, Sigilon created a pipeline of potential therapies capable of producing molecules that may be missing or deficient in the body—potentially resulting in functional cures for patients with a wide range of chronic diseases.

Sigilon Therapeutics, Inc.

Temasek

Corporate Advisor

EQT is a purpose-driven global investment organization, focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. Uniquely, EQT is the only large private markets firm in the world with investment strategies covering all phases of a business’ development, from start-up to maturity. EQT today has more than EUR 70 billion in assets under management across 27 active funds within two business segments

EQT Partners/EQT AB

Industrial Advisor

Sponsored by Patient Square Capital
Chair: Governance and Compensation Committees. Audit committee member
Merged with Roivant 2021





Merged with Roivant 2021

Montes Archimedes Acquistion Corp (NASDAQ: MAACU)

Privately held product software engineering company.  Acquired by Hitachi in July 2021

Stephen Oesterle